Skip to main content
Clinical Trials/NL-OMON52628
NL-OMON52628
Recruiting
Not Applicable

Optimizing diagnosis of splanchnic vein thrombosis with MR Direct Thrombus Imaging. - Rhea study

eids Universitair Medisch Centrum0 sites50 target enrollmentStarted: TBDLast updated:

Overview

Phase
Not Applicable
Status
Recruiting
Enrollment
50

Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational non invasive

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • \- Patients with confirmed acute SVT; definitions provided in paragraph 4\.2 in
  • the Rhea study protocol (Cases, group 1\)
  • \- Patients with confirmed non\-symptomatic chronic SVT, defined by incident SVT
  • with chronic thrombi on 2 serial imaging tests with at least 3 months interval
  • (controls, group 2\)
  • \- Aged 18 years and older
  • \- Willing and able to give informed consent

Exclusion Criteria

  • \- MRI contra\-indication (including but not limited to a cardiac pacemaker or
  • subcutaneous defibrillator; vascular clips in the cerebral vessels; metal
  • splinter in the eye, a hearing aid that cannot be removed; a neurostimulator
  • that cannot be removed; a hydrocephalus pump)
  • \- A medical condition, associated illness or co\-morbid circumstances that
  • precludes completion of the study procedures (MRI and 90\-day follow\-up
  • assessment), including but not limited to life\-expectancy less than 3 months,
  • inability to lie flat, morbid obesity preventing use of MR and claustrophobia.
  • \- Patients with decompensated liver disease with Child\-Pugh class C cirrhosis
  • (since MRDTI evaluation will be inadequate in these patients)

Investigators

Similar Trials